Invisalign Expander for Palate Expansion
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effectiveness of the Invisalign Palatal Expander system against a traditional expander in promoting upper jaw growth in young patients. It targets those with dental issues such as a crossbite or a narrow upper jaw. Participants should have a mix of adult and baby teeth and no major dental work on specific molars. The goal is to determine if this new system performs as well as or better than the usual treatment. As an unphased trial, it allows participants to contribute to innovative dental solutions that could benefit future patients.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that the Invisalign Palatal Expander System is safe for palate expansion?
Research has shown that the Invisalign Palatal Expander System is safe and effective for widening the upper jaw in children. The FDA has approved this treatment, indicating it has passed safety checks for this specific use. The system's removable design offers convenience for patients.
Studies have found that this expander works well without causing major side effects. Reports of unexpected health problems remain rare, suggesting it is well-tolerated by patients. Overall, the evidence supports its safety in aiding jaw expansion for young patients.12345Why are researchers excited about this trial?
Researchers are excited about the Invisalign Palatal Expander System because it offers a less invasive and more aesthetically pleasing alternative to traditional palate expanders, like the Hyrax-type maxillary expander. Unlike the standard metal devices, the Invisalign system uses clear aligner technology, which is more comfortable for patients and nearly invisible when worn. This system also allows for greater precision and customization in adjusting the palate, potentially leading to more efficient treatment outcomes.
What evidence suggests that the Invisalign Palatal Expander System is effective for palate expansion?
Research has shown that the Invisalign Palatal Expander System, one of the treatments studied in this trial, effectively widens the upper jaw in growing children. Studies have found that it successfully expands the midline of the palate, helping to make the upper jaw wider. This system offers a less invasive option compared to traditional expanders like the Hyrax-type, which is another treatment arm in this trial and uses metal parts and screws. Early results suggest that Invisalign can be a safer and effective choice for expanding the dental arch, especially when the upper jaw is narrow. Overall, the Invisalign Palatal Expander System promises jaw expansion without the discomfort of traditional methods.25678
Who Is on the Research Team?
Heeyeon Suh
Principal Investigator
University of the Pacific
Are You a Good Fit for This Trial?
This trial is for patients with a narrow upper jaw presenting as unilateral or bilateral posterior crossbite, who are in the mixed or early permanent dentition phase without fully erupted second molars. Participants must have stable teeth and be willing to consent. Those with craniofacial anomalies, Class III skeletal profile, or significant health issues affecting treatment are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the Invisalign Palatal Expander System or the Hyrax-type maxillary expander
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Invisalign Palatal Expander System
Invisalign Palatal Expander System is already approved in European Union for the following indications:
- Skeletal and dental expansion in growing patients
- Orthodontic treatment of malocclusion
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of the Pacific
Lead Sponsor